Inpefa 400mg (Sotagliflozin Tablet) 400 mg

Inpefa 400mg (sotagliflozin) is a prescription tablet used to support heart and kidney health in adults with certain conditions. This 400 mg strength medication is taken orally and stored below 25°C. Sotagliflozin belongs to a class of medicines that help manage blood sugar and reduce strain on the heart.

Strength

400 mg

Pack Size

30s

Storage

Below 25°C

Manufacturer / TM Owner

Lexicon Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inpefa 400mg is primarily used alongside diet and exercise to improve outcomes for adults with type 2 diabetes who also have heart failure or chronic kidney disease. It works by helping the body remove excess glucose through urine, which may reduce the workload on the heart and kidneys. This medication is not a first-line treatment and is typically prescribed when other options have not provided sufficient control.

Side Effects

Many people taking Inpefa 400mg notice increased urination as the body adjusts to removing more glucose. Some may experience mild digestive changes or temporary fatigue as common early effects. These effects often lessen over time as the body adapts to the medication.

Precautions & Warnings

Inpefa 400mg should be kept in its original packaging and stored below 25°C to maintain effectiveness. Patients should stay well-hydrated while taking this medication to support kidney function. It is important to attend regular check-ups to monitor how the body responds to treatment.

Avoid Interactions

Alcohol may increase the risk of dehydration or low blood sugar when combined with Inpefa 400mg. Certain medications, such as diuretics or insulin, may interact with sotagliflozin, potentially affecting blood sugar levels. Always inform your healthcare provider about all medications and supplements you are taking before starting this treatment.

Frequently Asked Questions

Inpefa 400mg is used to support heart and kidney health in adults with type 2 diabetes who also have heart failure or chronic kidney disease.

Store Inpefa 400mg below 25°C in its original packaging to protect it from moisture and light.

Alcohol may increase the risk of dehydration or low blood sugar; consult your healthcare provider for personalized advice.

Common effects may include increased urination, mild digestive changes, or temporary fatigue as the body adjusts.

No, it is typically prescribed when other diabetes treatments have not provided sufficient control.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.